CoChat

Optogenetic approaches to vision restoration

Open access
Simunovic, M.P., Shen, W., Lin, J.Y., Protti, D.A., Lisowski, L., Gillies, M.C. · 2019 · Experimental Eye Research
Cited by 109

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Inherited retinal disease (IRD) affects about 1 in 3000 to 1 in 5000 individuals and is now believed to be the most common cause of blindness registration in developed countries. Until recently, the management of such conditions had been exclusively supportive. However, advances in molecular biology and medical engineering have now seen the rise of a variety of approaches to restore vision in patients with IRDs. Optogenetic approaches are primarily aimed at rendering secondary and tertiary neurons of the retina light‐sensitive in order to replace degenerate or dysfunctional photoreceptors. Such approaches are attractive because they provide a “causative gene‐independent” strategy, which may prove suitable for a variety of patients with IRD. We discuss theoretical and practical considerations in the selection of optogenetic molecules, vectors, surgical approaches and review previous trials of optogenetics for vision restoration. Optogenetic approaches to vision restoration have yielded promising results in pre‐clinical trials and a phase I/II clinical trial is currently underway (ClinicalTrials.gov NCT02556736). Despite the significant inroads made in recent years, the ideal optogenetic molecule, vector and surgical approach have yet to be established. HighlightsOptogenetic approaches to vision restoration seek to restore vision to patients with inherited retinal diseases by rendering secondary and tertiary neurones of the retina light‐sensitive.Two principal classes of molecule can be used: Type 1 (microbial) opsins or Type 2 (animal) opsins.Pre‐clinical trials of optogenetic approaches in animal models suggest that the technique may restore vision in previously blind animals, with the threshold for activation being within 1‐2 log units of the threshold for cone activation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.exer.2018.09.003

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 62

  1. Aboshiha, 2014, Dark-adaptation functions in molecularly confirmed achromatopsia and the implications for assessment in retinal therapy trials, Invest. Ophthalmol. Vis. Sci., 55, 6340, 10.1167/iovs.14-14910 · DOI
  2. Ahnelt, 1998, The photoreceptor mosaic, Eye, 12, 531, 10.1038/eye.1998.142 · DOI
  3. Ahnelt, 2000, The mammalian photoreceptor mosaic-adaptive design, Prog. Retin. Eye Res., 19, 711, 10.1016/S1350-9462(00)00012-4 · DOI · Paper page
  4. Ait-Ali, 2015, Rod-derived cone viability factor promotes cone survival by stimulating aerobic glycolysis, Cell, 161, 817, 10.1016/j.cell.2015.03.023 · DOI · Paper page
  5. Ameline, 2017, Long-term expression of melanopsin and channelrhodopsin causes no gross alterations in the dystrophic dog retina, Gene Ther., 10.1038/gt.2017.63 · DOI
  6. Barlow, 1957, Purkinje shift and retinal noise, Nature, 179, 255, 10.1038/179255b0 · DOI
  7. Bi, 2006, Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration, Neuron, 50, 23, 10.1016/j.neuron.2006.02.026 · DOI · Paper page
  8. Bird, 1995, Retinal photoreceptor dystrophies LI. Edward Jackson Memorial lecture, Am. J. Ophthalmol., 119, 543, 10.1016/S0002-9394(14)70212-0 · DOI · Paper page
  9. Busskamp, 2010, Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa, Science, 329, 413, 10.1126/science.1190897 · DOI · Paper page
  10. Callaway, 2005, Structure and function of parallel pathways in the primate early visual system, J. Physiol., 566, 13, 10.1113/jphysiol.2005.088047 · DOI · Paper page
  11. Carroll, 1952, Congenital stationary night blindness without ophthalmoscopic or other abnormalities, Trans. Am. Ophthalmol. Soc., 50, 193
  12. Chaffiol, 2017, A new promoter allows optogenetic vision restoration with enhanced sensitivity in macaque retina, Mol. Ther., 25, 2546, 10.1016/j.ymthe.2017.07.011 · DOI
  13. Cronin, 2014, Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno-associated virus capsid and promoter, EMBO Mol. Med., 6, 1175, 10.15252/emmm.201404077 · DOI · Paper page
  14. Dartnall, 1983, Human visual pigments: microspectrophotometric results from the eyes of seven persons, Proc. R. Soc. Lond. B Biol. Sci., 220, 115, 10.1098/rspb.1983.0091 · DOI · Paper page
  15. Day, 2014, Advances in AAV vector development for gene therapy in the retina, Adv. Exp. Med. Biol., 801, 687, 10.1007/978-1-4614-3209-8_86 · DOI
  16. De Silva, 2017, Long-term restoration of visual function in end-stage retinal degeneration using subretinal human melanopsin gene therapy, Proc. Natl. Acad. Sci. U. S. A., 114, 11211, 10.1073/pnas.1701589114 · DOI · Paper page
  17. Di Marco, 2009, Permanent functional reorganization of retinal circuits induced by early long-term visual deprivation, J. Neurosci., 29, 13691, 10.1523/JNEUROSCI.3854-09.2009 · DOI
  18. Do, 2008, Surgery for post-vitrectomy cataract, Cochrane Database Syst. Rev., 10.1002/14651858.CD006366.pub2 · DOI
  19. Doroudchi, 2011, Virally delivered channelrhodopsin-2 safely and effectively restores visual function in multiple mouse models of blindness, Mol. Ther., 19, 1220, 10.1038/mt.2011.69 · DOI · Paper page
  20. Duebel, 2015, Optogenetics, Curr. Opin. Ophthalmol., 26, 226, 10.1097/ICU.0000000000000140 · DOI
  21. Gaub, 2015, Optogenetic vision restoration using rhodopsin for enhanced sensitivity, Mol. Ther., 23, 1562, 10.1038/mt.2015.121 · DOI · Paper page
  22. Grunwald, 1996, Retinal hemodynamics in retinitis pigmentosa, Am. J. Ophthalmol., 122, 502, 10.1016/S0002-9394(14)72109-9 · DOI · Paper page
  23. Ham, 1984, Basic mechanisms underlying the production of photochemical lesions in the mammalian retina, Curr. Eye Res., 3, 165, 10.3109/02713688408997198 · DOI · Paper page
  24. Hood, 1993, Human cone receptor activity: the leading edge of the a-wave and models of receptor activity, Vis. Neurosci., 10, 857, 10.1017/S0952523800006076 · DOI · Paper page
  25. Hood, 1993, Light adaptation of human rod receptors: the leading edge of the human a-wave and models of rod receptor activity, Vis. Res., 33, 1605, 10.1016/0042-6989(93)90027-T · DOI · Paper page
  26. Hughes, 2016, Signalling by melanopsin (OPN4) expressing photosensitive retinal ganglion cells, Eye, 30, 247, 10.1038/eye.2015.264 · DOI
  27. Jacobson, 2013, Retinal optogenetic therapies: clinical criteria for candidacy, Clin. Genet., 84, 175, 10.1111/cge.12165 · DOI
  28. Jones, 2016, Retinal remodeling in human retinitis pigmentosa, Exp. Eye Res., 150, 149, 10.1016/j.exer.2016.03.018 · DOI · Paper page
  29. Kleinlogel, 2011, Ultra light-sensitive and fast neuronal activation with the Ca(2)+-permeable channelrhodopsin CatCh, Nat. Neurosci., 14, 513, 10.1038/nn.2776 · DOI · Paper page
  30. Lagali, 2008, Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration, Nat. Neurosci., 11, 667, 10.1038/nn.2117 · DOI · Paper page
  31. Leveillard, 2004, Identification and characterization of rod-derived cone viability factor, Nat. Genet., 36, 755, 10.1038/ng1386 · DOI · Paper page
  32. Liew, 2014, A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010, BMJ Open, 4, 10.1136/bmjopen-2013-004015 · DOI · Paper page
  33. Lin, 2008, Restoration of visual function in retinal degeneration mice by ectopic expression of melanopsin, Proc. Natl. Acad. Sci. U. S. A., 105, 16009, 10.1073/pnas.0806114105 · DOI · Paper page
  34. Lin, 2011, A user's guide to channelrhodopsin variants: features, limitations and future developments, Exp. Physiol., 96, 19, 10.1113/expphysiol.2009.051961 · DOI · Paper page
  35. Liu, 2016, Human melanopsin-AAV2/8 transfection to retina transiently restores visual function in rd1 mice, Int. J. Ophthalmol., 9, 655
  36. Mace, 2015, Targeting channelrhodopsin-2 to ON-bipolar cells with vitreally administered AAV Restores ON and OFF visual responses in blind mice, Mol. Ther., 23, 7, 10.1038/mt.2014.154 · DOI · Paper page
  37. Masland, 2012, The neuronal organization of the retina, Neuron, 76, 266, 10.1016/j.neuron.2012.10.002 · DOI · Paper page
  38. Mollon, 1989, “Tho' she kneel'd in that place where they grew...” the uses and origins of primate colour vision, J. Exp. Biol., 146, 21, 10.1242/jeb.146.1.21 · DOI · Paper page
  39. Mollon, 1998, What is the function of the cone-rich rim of the retina?, Eye, 12, 548, 10.1038/eye.1998.144 · DOI
  40. Moore, 2017, Genetic testing for inherited retinal disease, Ophthalmology, 124, 1254, 10.1016/j.ophtha.2017.06.018 · DOI
  41. Ochakovski, 2017, Retinal gene therapy: surgical vector delivery in the translation to clinical trials, Front. Neurosci., 11, 174, 10.3389/fnins.2017.00174 · DOI · Paper page
  42. Osorio, 2004, Visual pigments: trading noise for fast recovery, Curr. Biol., 14, R1051, 10.1016/j.cub.2004.11.044 · DOI
  43. Patricio, 2017, Inclusion of the Woodchuck hepatitis virus posttranscriptional regulatory element enhances AAV2-driven transduction of mouse and human retina, Mol. Ther. Nucleic Acids, 6, 198, 10.1016/j.omtn.2016.12.006 · DOI · Paper page
  44. Russell, 2017, Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial, Lancet, 390, 849, 10.1016/S0140-6736(17)31868-8 · DOI · Paper page
  45. Sato, 2017, Visual responses of photoreceptor-degenerated rats expressing two different types of channelrhodopsin genes, Sci. Rep., 7, 41210, 10.1038/srep41210 · DOI
  46. Schiller, 1986, Functions of the ON and OFF channels of the visual system, Nature, 322, 824, 10.1038/322824a0 · DOI · Paper page
  47. Semo, 2003, Melanopsin retinal ganglion cells and the maintenance of circadian and pupillary responses to light in aged rodless/coneless (rd/rd cl) mice, Eur. J. Neurosci., 17, 1793, 10.1046/j.1460-9568.2003.02616.x · DOI · Paper page
  48. Sengupta, 2016, Red-shifted channelrhodopsin stimulation restores light responses in blind mice, macaque retina, and human retina, EMBO Mol. Med., 8, 1248, 10.15252/emmm.201505699 · DOI · Paper page
  49. Sharpe, 2005, A luminous efficiency function, V*(lambda), for daylight adaptation, J. Vis., 5, 948, 10.1167/5.11.3 · DOI · Paper page
  50. Silveira, 1999, Ganglion cells of a short-wavelength-sensitive cone pathway in New World monkeys: morphology and physiology, Vis. Neurosci., 16, 333, 10.1017/S0952523899162138 · DOI
  51. Simunovic, 1998, The cone dystrophies, Eye, 12, 553, 10.1038/eye.1998.145 · DOI
  52. Simunovic, 2017, Structural and functional recovery following limited iatrogenic macular detachment for retinal gene therapy, JAMA Ophthalmol, 135, 234, 10.1001/jamaophthalmol.2016.5630 · DOI · Paper page
  53. Stabell, 1996, Peripheral colour vision: effects of rod intrusion at different eccentricities, Vis. Res., 36, 3407, 10.1016/0042-6989(96)00079-X · doi:10.1016/0042-6989(96)00079-x
  54. Thyagarajan, 2010, Visual function in mice with photoreceptor degeneration and transgenic expression of channelrhodopsin 2 in ganglion cells, J. Neurosci., 30, 8745, 10.1523/JNEUROSCI.4417-09.2010 · DOI · Paper page
  55. Tomita, 2010, Channelrhodopsin-2 gene transduced into retinal ganglion cells restores functional vision in genetically blind rats, Exp. Eye Res., 90, 429, 10.1016/j.exer.2009.12.006 · DOI · Paper page
  56. Tomita, 2014, Restoration of the majority of the visual spectrum by using modified Volvox channelrhodopsin-1, Mol. Ther., 22, 1434, 10.1038/mt.2014.81 · DOI
  57. Tomita, 2007, Restoration of visual response in aged dystrophic RCS rats using AAV-mediated channelopsin-2 gene transfer, Invest. Ophthalmol. Vis. Sci., 48, 3821, 10.1167/iovs.06-1501 · DOI · Paper page
  58. van Wyk, 2015, Restoring the ON switch in blind retinas: opto-mGluR6, a next-generation, cell-tailored optogenetic tool, PLoS Biol., 13, 10.1371/journal.pbio.1002143 · DOI · Paper page
  59. von Noorden, 1978, Application of basic research data to clinical amblyopia, Ophthalmology, 85, 496, 10.1016/S0161-6420(78)35652-9 · doi:10.1016/s0161-6420(78)35652-9
  60. Wright, 1997, A searchlight through the fog, Nat. Genet., 17, 132, 10.1038/ng1097-132 · DOI
  61. Zeng, 2017, Neuronal cell-type classification: challenges, opportunities and the path forward, Nat. Rev. Neurosci., 18, 530, 10.1038/nrn.2017.85 · DOI · Paper page
  62. Zhang, 2009, Ectopic expression of multiple microbial rhodopsins restores ON and OFF light responses in retinas with photoreceptor degeneration, J. Neurosci., 29, 9186, 10.1523/JNEUROSCI.0184-09.2009 · DOI · Paper page

Cited by

See all 109

Metadata

Authors
Simunovic, M. P., Shen, W., Lin, J. Y., Protti, D. A., Lisowski, L., & Gillies, M. C.
Venue
Experimental Eye Research
Publisher
Elsevier BV
Published
2019-01
Volume
178
Pages
15-26
ISSN
0014-4835 (ISSN-L)
OpenAlex
W2890167217
Cited by
109
References
14
FWCI
5.20
Type
journal article
Language
en
Open access
green
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • Foundation Fighting Blindness USA
  • Career Development Award (CD-CL-0816-0710-SYD)
  • Sydney Medical School Foundation (RY502)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Optogenetic approaches to vision restoration. https://app.cochat.ai/papers/10.1016/j.exer.2018.09.003
The paper
Simunovic, M. P., Shen, W., Lin, J. Y., Protti, D. A., Lisowski, L., & Gillies, M. C. (2019). Optogenetic approaches to vision restoration. Experimental Eye Research. https://doi.org/10.1016/j.exer.2018.09.003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.